News by Subject Social & Behavior

Differences in the way women with obesity burn calories during pregnancy may be a contributor to long-term postpartum weight retention in black moms. The findings, which suggest a need for more individualized pregnancy weight gain recommendations for obese women, will be presented today at the APS annual meeting at Experimental Biology 2018 in San Diego.

A new study published today in the journal PLOS ONE details how a compound called EP055 binds to sperm proteins to significantly slow the overall mobility of the sperm without affecting hormones, making EP055 a potential 'male pill' without side effects.

New research shows that online ads encouraging pregnant women to take up stop smoking support could be more effective than advice delivered in a clinical setting. The new study shows that commercial online advertising about cessation support could engage large numbers of women earlier in their pregnancies, and at a lower cost.

Pre-school children in sub-Saharan Africa should be tested regularly for a common infection known as snail fever, which would reduce the spread of the disease.

A Duke-led study publishing April 17 in the Journal of the American Medical Association followed women for five years after two common prolapse surgeries and found failure rates for both procedures were equally high, at over 60 percent.

Ninety-five percent of Canadian women have used vaginal hygiene products and a new study shows that these products might be doing more harm than good.

Taking painkillers during pregnancy could affect the fertility of the unborn child in later life, research suggests. Scientists at the University of Edinburgh looked at the effects of paracetamol (acetaminophen) and ibuprofen on samples of human fetal testes and ovaries. Their findings add to a growing body of evidence that the medicines should be used with caution during pregnancy.

A new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients' own immune cells, which are exposed to the contents of the patients' tumor cells, and injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, showed that about half of the vaccinated patients had signs of anti-tumor T-cell responses. The study is published today in Science Translational Medicine.